Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 22 |
NetGPI | no | yes: 0, no: 22 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0005739 | mitochondrion | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
Related structures:
AlphaFold database: A4HLY4
Term | Name | Level | Count |
---|---|---|---|
GO:0000959 | mitochondrial RNA metabolic process | 6 | 2 |
GO:0000963 | mitochondrial RNA processing | 6 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009987 | cellular process | 1 | 2 |
GO:0010467 | gene expression | 4 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0016556 | mRNA modification | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:0140053 | mitochondrial gene expression | 5 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 328 | 332 | PF00656 | 0.515 |
CLV_C14_Caspase3-7 | 389 | 393 | PF00656 | 0.483 |
CLV_NRD_NRD_1 | 159 | 161 | PF00675 | 0.605 |
CLV_NRD_NRD_1 | 231 | 233 | PF00675 | 0.481 |
CLV_NRD_NRD_1 | 324 | 326 | PF00675 | 0.451 |
CLV_NRD_NRD_1 | 413 | 415 | PF00675 | 0.354 |
CLV_NRD_NRD_1 | 432 | 434 | PF00675 | 0.468 |
CLV_PCSK_KEX2_1 | 159 | 161 | PF00082 | 0.589 |
CLV_PCSK_KEX2_1 | 231 | 233 | PF00082 | 0.481 |
CLV_PCSK_KEX2_1 | 324 | 326 | PF00082 | 0.467 |
CLV_PCSK_KEX2_1 | 375 | 377 | PF00082 | 0.372 |
CLV_PCSK_KEX2_1 | 432 | 434 | PF00082 | 0.397 |
CLV_PCSK_PC1ET2_1 | 375 | 377 | PF00082 | 0.421 |
CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.684 |
CLV_PCSK_SKI1_1 | 256 | 260 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 493 | 497 | PF00082 | 0.422 |
DOC_MAPK_gen_1 | 159 | 167 | PF00069 | 0.566 |
DOC_MAPK_gen_1 | 265 | 273 | PF00069 | 0.475 |
DOC_MAPK_gen_1 | 432 | 438 | PF00069 | 0.407 |
DOC_MAPK_gen_1 | 459 | 468 | PF00069 | 0.266 |
DOC_MAPK_MEF2A_6 | 357 | 365 | PF00069 | 0.376 |
DOC_MAPK_MEF2A_6 | 419 | 428 | PF00069 | 0.419 |
DOC_PP1_RVXF_1 | 230 | 237 | PF00149 | 0.423 |
DOC_PP1_RVXF_1 | 254 | 260 | PF00149 | 0.478 |
DOC_SPAK_OSR1_1 | 349 | 353 | PF12202 | 0.392 |
DOC_SPAK_OSR1_1 | 364 | 368 | PF12202 | 0.370 |
DOC_USP7_MATH_1 | 206 | 210 | PF00917 | 0.502 |
DOC_USP7_MATH_1 | 290 | 294 | PF00917 | 0.389 |
DOC_USP7_MATH_1 | 315 | 319 | PF00917 | 0.424 |
DOC_USP7_MATH_1 | 497 | 501 | PF00917 | 0.682 |
DOC_USP7_MATH_1 | 99 | 103 | PF00917 | 0.398 |
DOC_WW_Pin1_4 | 396 | 401 | PF00397 | 0.431 |
DOC_WW_Pin1_4 | 431 | 436 | PF00397 | 0.405 |
LIG_14-3-3_CanoR_1 | 268 | 272 | PF00244 | 0.455 |
LIG_14-3-3_CanoR_1 | 41 | 48 | PF00244 | 0.655 |
LIG_14-3-3_CanoR_1 | 493 | 501 | PF00244 | 0.427 |
LIG_Actin_WH2_2 | 158 | 173 | PF00022 | 0.540 |
LIG_Actin_WH2_2 | 375 | 390 | PF00022 | 0.516 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.542 |
LIG_deltaCOP1_diTrp_1 | 149 | 156 | PF00928 | 0.599 |
LIG_deltaCOP1_diTrp_1 | 235 | 242 | PF00928 | 0.404 |
LIG_deltaCOP1_diTrp_1 | 58 | 64 | PF00928 | 0.455 |
LIG_FHA_1 | 268 | 274 | PF00498 | 0.582 |
LIG_FHA_1 | 351 | 357 | PF00498 | 0.458 |
LIG_FHA_1 | 423 | 429 | PF00498 | 0.373 |
LIG_FHA_1 | 432 | 438 | PF00498 | 0.398 |
LIG_FHA_1 | 54 | 60 | PF00498 | 0.558 |
LIG_FHA_2 | 130 | 136 | PF00498 | 0.616 |
LIG_FHA_2 | 138 | 144 | PF00498 | 0.631 |
LIG_FHA_2 | 196 | 202 | PF00498 | 0.483 |
LIG_GBD_Chelix_1 | 303 | 311 | PF00786 | 0.441 |
LIG_LIR_Gen_1 | 163 | 172 | PF02991 | 0.544 |
LIG_LIR_Gen_1 | 174 | 184 | PF02991 | 0.514 |
LIG_LIR_Gen_1 | 449 | 460 | PF02991 | 0.361 |
LIG_LIR_Gen_1 | 51 | 60 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 163 | 167 | PF02991 | 0.560 |
LIG_LIR_Nem_3 | 174 | 179 | PF02991 | 0.543 |
LIG_LIR_Nem_3 | 449 | 455 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 51 | 55 | PF02991 | 0.431 |
LIG_SH2_CRK | 184 | 188 | PF00017 | 0.426 |
LIG_SH2_CRK | 260 | 264 | PF00017 | 0.480 |
LIG_SH2_CRK | 475 | 479 | PF00017 | 0.479 |
LIG_SH2_SRC | 281 | 284 | PF00017 | 0.435 |
LIG_SH2_SRC | 381 | 384 | PF00017 | 0.384 |
LIG_SH2_STAP1 | 176 | 180 | PF00017 | 0.512 |
LIG_SH2_STAP1 | 450 | 454 | PF00017 | 0.313 |
LIG_SH2_STAT3 | 79 | 82 | PF00017 | 0.399 |
LIG_SH2_STAT5 | 215 | 218 | PF00017 | 0.494 |
LIG_SH2_STAT5 | 286 | 289 | PF00017 | 0.468 |
LIG_SH2_STAT5 | 355 | 358 | PF00017 | 0.364 |
LIG_SH2_STAT5 | 381 | 384 | PF00017 | 0.525 |
LIG_SH2_STAT5 | 407 | 410 | PF00017 | 0.360 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.398 |
LIG_SH3_3 | 340 | 346 | PF00018 | 0.494 |
LIG_SH3_3 | 394 | 400 | PF00018 | 0.453 |
LIG_SH3_3 | 451 | 457 | PF00018 | 0.362 |
LIG_SH3_3 | 91 | 97 | PF00018 | 0.675 |
LIG_SUMO_SIM_anti_2 | 451 | 457 | PF11976 | 0.484 |
LIG_SUMO_SIM_anti_2 | 461 | 467 | PF11976 | 0.525 |
LIG_SUMO_SIM_anti_2 | 88 | 96 | PF11976 | 0.385 |
LIG_SUMO_SIM_par_1 | 434 | 439 | PF11976 | 0.439 |
LIG_SUMO_SIM_par_1 | 464 | 471 | PF11976 | 0.465 |
LIG_SUMO_SIM_par_1 | 88 | 96 | PF11976 | 0.385 |
LIG_TYR_ITIM | 258 | 263 | PF00017 | 0.455 |
LIG_TYR_ITIM | 448 | 453 | PF00017 | 0.378 |
MOD_CK1_1 | 189 | 195 | PF00069 | 0.467 |
MOD_CK1_1 | 393 | 399 | PF00069 | 0.425 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.487 |
MOD_CK1_1 | 88 | 94 | PF00069 | 0.576 |
MOD_CK2_1 | 137 | 143 | PF00069 | 0.699 |
MOD_CK2_1 | 292 | 298 | PF00069 | 0.413 |
MOD_CK2_1 | 70 | 76 | PF00069 | 0.411 |
MOD_CMANNOS | 61 | 64 | PF00535 | 0.399 |
MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.496 |
MOD_GlcNHglycan | 124 | 128 | PF01048 | 0.610 |
MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.652 |
MOD_GlcNHglycan | 190 | 194 | PF01048 | 0.564 |
MOD_GlcNHglycan | 246 | 249 | PF01048 | 0.372 |
MOD_GlcNHglycan | 292 | 295 | PF01048 | 0.499 |
MOD_GlcNHglycan | 44 | 47 | PF01048 | 0.645 |
MOD_GlcNHglycan | 72 | 75 | PF01048 | 0.350 |
MOD_GSK3_1 | 386 | 393 | PF00069 | 0.426 |
MOD_GSK3_1 | 489 | 496 | PF00069 | 0.575 |
MOD_N-GLC_1 | 117 | 122 | PF02516 | 0.487 |
MOD_N-GLC_1 | 244 | 249 | PF02516 | 0.292 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.627 |
MOD_NEK2_1 | 241 | 246 | PF00069 | 0.404 |
MOD_NEK2_1 | 259 | 264 | PF00069 | 0.564 |
MOD_NEK2_1 | 338 | 343 | PF00069 | 0.405 |
MOD_NEK2_1 | 350 | 355 | PF00069 | 0.356 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.731 |
MOD_NEK2_1 | 428 | 433 | PF00069 | 0.369 |
MOD_NEK2_1 | 436 | 441 | PF00069 | 0.461 |
MOD_NEK2_1 | 491 | 496 | PF00069 | 0.525 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.360 |
MOD_PIKK_1 | 355 | 361 | PF00454 | 0.360 |
MOD_PIKK_1 | 417 | 423 | PF00454 | 0.517 |
MOD_PKA_1 | 100 | 106 | PF00069 | 0.570 |
MOD_PKA_2 | 17 | 23 | PF00069 | 0.715 |
MOD_PKA_2 | 267 | 273 | PF00069 | 0.591 |
MOD_PKA_2 | 387 | 393 | PF00069 | 0.495 |
MOD_Plk_1 | 117 | 123 | PF00069 | 0.475 |
MOD_Plk_1 | 137 | 143 | PF00069 | 0.680 |
MOD_Plk_1 | 50 | 56 | PF00069 | 0.480 |
MOD_Plk_1 | 88 | 94 | PF00069 | 0.397 |
MOD_Plk_4 | 100 | 106 | PF00069 | 0.467 |
MOD_Plk_4 | 393 | 399 | PF00069 | 0.425 |
MOD_Plk_4 | 4 | 10 | PF00069 | 0.735 |
MOD_Plk_4 | 88 | 94 | PF00069 | 0.667 |
MOD_ProDKin_1 | 396 | 402 | PF00069 | 0.425 |
MOD_ProDKin_1 | 431 | 437 | PF00069 | 0.408 |
TRG_DiLeu_BaLyEn_6 | 432 | 437 | PF01217 | 0.410 |
TRG_ENDOCYTIC_2 | 164 | 167 | PF00928 | 0.612 |
TRG_ENDOCYTIC_2 | 176 | 179 | PF00928 | 0.377 |
TRG_ENDOCYTIC_2 | 184 | 187 | PF00928 | 0.381 |
TRG_ENDOCYTIC_2 | 260 | 263 | PF00928 | 0.456 |
TRG_ENDOCYTIC_2 | 286 | 289 | PF00928 | 0.401 |
TRG_ENDOCYTIC_2 | 450 | 453 | PF00928 | 0.347 |
TRG_ENDOCYTIC_2 | 475 | 478 | PF00928 | 0.482 |
TRG_ER_diArg_1 | 230 | 232 | PF00400 | 0.392 |
TRG_ER_diArg_1 | 323 | 325 | PF00400 | 0.417 |
TRG_ER_diArg_1 | 367 | 370 | PF00400 | 0.377 |
TRG_NES_CRM1_1 | 298 | 313 | PF08389 | 0.529 |
TRG_NLS_MonoExtC_3 | 373 | 379 | PF00514 | 0.407 |
TRG_NLS_MonoExtN_4 | 372 | 378 | PF00514 | 0.451 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IK37 | Leptomonas seymouri | 28% | 100% |
A0A0N1IKX3 | Leptomonas seymouri | 80% | 92% |
A0A0S4IN88 | Bodo saltans | 29% | 93% |
A0A0S4JQR1 | Bodo saltans | 57% | 93% |
A0A1X0NRA1 | Trypanosomatidae | 70% | 98% |
A0A1X0NTQ0 | Trypanosomatidae | 30% | 100% |
A0A3Q8II17 | Leishmania donovani | 87% | 100% |
A0A3S7WX47 | Leishmania donovani | 29% | 100% |
A0A422NDT8 | Trypanosoma rangeli | 30% | 100% |
A0A422NKD3 | Trypanosoma rangeli | 68% | 100% |
A4HCA9 | Leishmania braziliensis | 27% | 100% |
A4HZU2 | Leishmania infantum | 29% | 100% |
A4I9B3 | Leishmania infantum | 87% | 100% |
C9ZJB1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 68% | 100% |
C9ZRN1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 100% |
E9AVP7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9B4B3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q4Q3R2 | Leishmania major | 88% | 100% |
Q4QBT2 | Leishmania major | 29% | 100% |
V5BAI0 | Trypanosoma cruzi | 69% | 100% |
V5BVS4 | Trypanosoma cruzi | 30% | 100% |